Clinical Trial Update: A Study to Learn About the Study Medicine (Maplirpacept) in People With Advanced Non-Hodgkin Lymphoma or Multiple Myeloma in China [Phase 1]

View source ↗

Summary

Phase 1 clinical trial update evaluating Maplirpacept in advanced non-Hodgkin lymphoma or multiple myeloma in China has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma
• Non-hodgkin Lymphoma

Drugs mentioned

• Maplirpacept (PF-07901801)

Snippet

Sponsor: Pfizer | Conditions: Non-Hodgkin Lymphoma, Multiple Myeloma | Phase 1 | Status: COMPLETED